Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 36 | $14,732,038 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
12 Nov 2024 16:15 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 07 Nov 2024 | Sale | 5,000 | 102 | 510,000 | D |
08 Nov 2024 16:53 | SYRE | Spyre Therapeutics Inc | ALBERS JEFFREY W. | Director | 06 Nov 2024 | Sale | 6,700 | 36.7631 | 246,313 | I |
28 Oct 2024 16:41 | SYRE | Spyre Therapeutics Inc | ALBERS JEFFREY W. | Director | 25 Oct 2024 | Sale | 300 | 36.43 | 10,929 | I |
11 Sep 2024 16:06 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 09 Sep 2024 | Sale | 7,734 | 85.12 | 658,318 | D |
11 Sep 2024 16:06 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 09 Sep 2024 | Sale | 11,968 | 85.86 | 1,027,572 | D |
26 Aug 2024 18:31 | KYMR | Kymera Therapeutics Inc | ALBERS JEFFREY W. | Director | 26 Aug 2024 | Sale | 5,000 | 49.1017 | 245,508 | D |
26 Mar 2024 21:11 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 07 Mar 2024 | Sale | 11,033 | 90.69 | 1,000,583 | D |
22 Mar 2024 17:50 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 20 Mar 2024 | Sale | 1,367 | 89.12 | 121,827 | D |
22 Mar 2024 17:50 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 20 Mar 2024 | Sale | 6,285 | 88.6 | 556,851 | D |
22 Mar 2024 17:50 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 20 Mar 2024 | Sale | 8,440 | 87.26 | 736,474 | D |
22 Mar 2024 17:50 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 20 Mar 2024 | Sale | 6,251 | 86.46 | 540,461 | D |
22 Mar 2024 17:50 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 20 Mar 2024 | Sale | 2,730 | 85.22 | 232,651 | D |
21 Feb 2024 18:46 | KYMR | Kymera Therapeutics Inc | ALBERS JEFFREY W. | Director | 21 Feb 2024 | Sale | 4,385 | 39.0483 | 171,227 | D |
21 Feb 2024 18:46 | KYMR | Kymera Therapeutics Inc | ALBERS JEFFREY W. | Director | 20 Feb 2024 | Sale | 615 | 39.0746 | 24,031 | D |
29 Jan 2024 18:13 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 25 Jan 2024 | Sale | 100 | 83.57 | 8,357 | D |
29 Jan 2024 18:13 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 25 Jan 2024 | Sale | 7,924 | 82.76 | 655,790 | D |
29 Jan 2024 18:13 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 25 Jan 2024 | Sale | 10,890 | 81.7 | 889,713 | D |
29 Jan 2024 18:13 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 25 Jan 2024 | Sale | 6,086 | 81.16 | 493,940 | D |
23 Jan 2024 19:37 | KYMR | Kymera Therapeutics Inc | ALBERS JEFFREY W. | Director | 23 Jan 2024 | Sale | 10,000 | 30.047 | 300,470 | D |
13 Dec 2023 15:56 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 11 Dec 2023 | Sale | 5,000 | 79.07 | 395,350 | D |
04 Dec 2023 16:02 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 30 Nov 2023 | Sale | 5,000 | 70.55 | 352,750 | D |
28 Nov 2023 16:05 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 24 Nov 2023 | Sale | 7,036 | 67.81 | 477,111 | D |
28 Nov 2023 16:05 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 24 Nov 2023 | Sale | 7,964 | 67.25 | 535,579 | D |
03 Nov 2023 17:07 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 03 Nov 2023 | Sale | 1,485 | 60.13 | 89,293 | D |
03 Nov 2023 17:07 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 02 Nov 2023 | Sale | 59 | 61.05 | 3,602 | D |
03 Nov 2023 17:07 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 02 Nov 2023 | Sale | 4,575 | 60.36 | 276,147 | D |
03 Nov 2023 17:07 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 01 Nov 2023 | Sale | 3,881 | 60.02 | 232,938 | D |
29 Sep 2023 14:36 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 27 Sep 2023 | Sale | 400 | 50.5 | 20,200 | D |
29 Sep 2023 14:36 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 28 Sep 2023 | Sale | 6,898 | 50.17 | 346,073 | D |
29 Sep 2023 14:36 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 27 Sep 2023 | Sale | 12,102 | 49.93 | 604,253 | D |
29 Sep 2023 14:36 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 27 Sep 2023 | Sale | 5,600 | 48.84 | 273,504 | D |
28 Aug 2023 18:23 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 25 Aug 2023 | Sale | 10,000 | 50.16 | 501,600 | D |
28 Aug 2023 18:23 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 24 Aug 2023 | Sale | 15,000 | 49.57 | 743,550 | D |
08 Mar 2023 21:28 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 06 Mar 2023 | Sale | 319 | 44.27 | 14,122 | D |
08 Mar 2023 21:28 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 06 Mar 2023 | Sale | 9,474 | 45.72 | 433,151 | D |
07 Dec 2022 20:52 | BPMC | Blueprint Medicines Corp | ALBERS JEFFREY W. | Director | 05 Dec 2022 | Sale | 20,000 | 50.09 | 1,001,800 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)